Literature DB >> 3667984

Regional distribution of cholecystokinin receptors in primate cerebral cortex determined by in vitro receptor autoradiography.

M F Kritzer1, R B Innis, P S Goldman-Rakic.   

Abstract

Cholecystokinin (CCK) is a putative peptide neurotransmitter present in high concentration in the cerebral cortex. By using techniques of in vitro receptor autoradiography, CCK binding sites in primate cortex were labeled with 125I-Bolton-Hunter-labeled CCK-33 (the 33-amino-acid C-terminal peptide) and 3H-CCK-8 (the C-terminal octapeptide). Biochemical studies performed on homogenized and slide-mounted tissue sections showed that the two ligands labeled a high-affinity, apparently single, saturable site. Autoradiography revealed that binding sites labeled by both ligands were anatomically indistinguishable and were distributed in two basic patterns. A faint and diffuse label characterized portions of medial prefrontal cortex, premotor and motor cortices, the superior parietal lobule, and the temporal pole. In other cortical areas the pattern of binding was layer-specific; i.e., binding sites were concentrated within particular cortical layers and were superimposed upon the background of diffuse label. Layer-specific label was found in the prefrontal cortex, anterior and posterior cingulate gyrus, somatosensory cortex, inferior parietal lobule, retrosplenial cortex, insula, temporal lobe cortices, and in the primary visual and adjacent visual association cortices. The areal and laminar localization of layer-specific CCK binding sites consistently coincided with the cortical projections of thalamic nuclei. In prefrontal cortex, CCK binding sites were present in layers III and IV, precisely paralleling the terminal fields of thalamocortical projections from the mediodorsal and medial pulvinar nucleus of the thalamus. In somatosensory cortex, the pattern of CCK binding in layer IV coincided with thalamic inputs arising from the ventrobasal complex, while in the posterior cingulate gyrus, insular cortex, and retrosplenial cortex, layer IV and lower III binding mirrored the laminar distribution of cortical afferents of the medial pulvinar. CCK binding in layers IVa, IVc alpha, IVc beta, and VI of primary visual cortex corresponded to the terminal field disposition of lateral geniculate neurons, whereas in adjacent visual association cortex, binding in layers III, IV, and VI faithfully followed the cortical distribution of projections from the inferior and lateral divisions of the pulvinar nucleus of the thalamus. We interpret the diffusely labeled binding sites in primate cortex as being associated with the intrinsic system of CCK-containing interneurons that are distributed throughout all layers and areas of the cortex. The stratified binding sites, however, appear to be associated with specific extrinsic peptidergic projections.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667984     DOI: 10.1002/cne.902630308

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  3 in total

1.  Postnatal development of somatostatin-containing neurons in the visual cortex of normal and dark-reared rats.

Authors:  G C Papadopoulos; M E Cavanagh; J Antonopoulos; H Michaloudi; J G Parnavelas
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

2.  Cholecystokinin from the entorhinal cortex enables neural plasticity in the auditory cortex.

Authors:  Xiao Li; Kai Yu; Zicong Zhang; Wenjian Sun; Zhou Yang; Jingyu Feng; Xi Chen; Chun-Hua Liu; Haitao Wang; Yi Ping Guo; Jufang He
Journal:  Cell Res       Date:  2013-12-17       Impact factor: 25.617

3.  Common genetic risk variants identified in the SPARK cohort support DDHD2 as a candidate risk gene for autism.

Authors:  Hyejung Won; Jason L Stein; Nana Matoba; Dan Liang; Huaigu Sun; Nil Aygün; Jessica C McAfee; Jessica E Davis; Laura M Raffield; Huijun Qian; Joseph Piven; Yun Li; Sriam Kosuri
Journal:  Transl Psychiatry       Date:  2020-08-03       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.